Poor Sleep Quality And Insomnia Associated With Suicidal Symptoms Among College Students

Poor sleep quality and insomnia are significantly associated with suicidal symptoms among college undergraduates, according to a research abstract presented on Monday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS).

Woman Suffer Less Sleep Complaints When Happily Married

Marital happiness may lower the risk of sleep problems in Caucasian women, while marital strife may heighten the risk, according to a research abstract presented on Monday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS).

Anti-estrogen Drug Therapy Reduces Risk Of Invasive Breast Cancer In Older Women

New analysis of a drug approved for osteoporosis prevention and treatment has provided definitive evidence that the medication is also effective as a breast cancer preventative for certain cancers. Women who took the drug raloxifene were less likely to develop invasive, estrogen-receptor (ER) positive breast cancer compared with women who did not take the drug.

Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials

Roche and Ipsen's investigational type 2 diabetes drug taspoglutide (R1583) has been shown to provide significant improvements in glucose control and weight loss after only eight weeks of treatment(1, 2) with a safety and tolerability profile that supports entry into Phase III.

HiCy Drug Regimen Reverses MS Symptoms In Selected Patients

A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report.

AMT Makes Important Advance In The Development Of Its Gene Therapy For Hemophilia B -Company Accesses Technology To Prevent Immune Response

Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced that it obtained a license from 'TIGET' San Raffaele Telethon Institute For Gene Therapy, Italy, to use their micro-RNA technology to prevent immune responses against gene therapy for Hemophilia B.

New CDC Study First To Present National Outdoor Recreational Injury Estimates

Almost 213, 000 people were treated each year in emergency departments for outdoor recreational injuries from 2004 to 2005, according to a Centers for Disease Control and Prevention (CDC) study in the journal Wilderness and Environmental Medicine. Of those injured, about 109, 000 (51.

First National Study To Examine Golf Cart-Related Injuries

The popularity of golf carts has skyrocketed in recent years, and unfortunately so has the number of golf cart-related injuries. In fact, a new study conducted by researchers in the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital found that the number of golf cart-related injuries rose 132 percent during the 17-year study period.

Diabetes Experts Respond To New Clinical Trials

The American Association of Clinical Endocrinologists (AACE) has been closely monitoring the results of two major clinical trials released this week, ADVANCE and ACCORD. The results of the studies highlight controversy concerning the benefits and risks of tight glycemic control.

A Blood Substitute's Effectiveness And Safety Addressed In Large Clinical Trial

A predicted shortfall of over 4 million units of blood worldwide is driving the need to develop an alternative to red blood cells.